Phase Holographic Imaging is a Sweden-based biotechnology startup that has been revolutionizing live cell analysis since its establishment in 2004. With the slogan "Discover the full story of your cells. Live cell analysis now is cell-friendly, automatic & right inside the incubator," the company has developed HoloMonitor®, a cutting-edge live cell analysis tool. This innovation enables label-free and kinetic live-cell imaging studies, making it affordable for any cell lab. Utilizing novel digital holography technology, Phase Holographic Imaging provides high-quality images and quantitative real-time data. Their multiple automatic live cell assays allow for the easy study of cell culture behavior down to the single-cell level, directly inside a standard incubator. The company recently received a significant kr4.50M investment in the form of Post-IPO Debt on May 17, 2024, with Bizcap AB being the investing entity. This injection of capital is expected to further fuel the expansion and development of Phase Holographic Imaging's groundbreaking technologies, solidifying its position as a leader in the live cell analysis space. With its innovative approach and impressive track record, Phase Holographic Imaging has the potential to make a lasting impact on the biotechnology industry and beyond.
No recent news or press coverage available for Phase Holographic Imaging.